Cover Image
市場調查報告書

心導管:開發平台分析

Cardiac Catheters - Medical Devices Pipeline Assessment, 2016

出版商 GlobalData 商品編碼 345367
出版日期 內容資訊 英文 252 Pages
訂單完成後即時交付
價格
Back to Top
心導管:開發平台分析 Cardiac Catheters - Medical Devices Pipeline Assessment, 2016
出版日期: 2016年12月01日 內容資訊: 英文 252 Pages
簡介

本報告提供全球各國的企業·醫療機關等正在開發的心導管開發中產品資訊相關分析,提供您臨床實驗與產品開發的進展,彙整各階段·各市場區隔·國家 (地區) 別趨勢,企業與產品的詳細資訊,最近的產品開發及產業趨勢等資訊。

第1章 目錄

第2章 簡介

  • 心導管概要

第3章 開發中的產品

  • 心導管 - 各開發階段的開發中產品
  • 心導管 - 各市場區隔的開發中產品
  • 心導管 -國家 (地區) 別的開發中產品
  • 心導管 - 法規別開發中產品
  • 心導管 - 各認證時期 (估計) 的開發中產品
  • 心導管 - 現在進行中的臨床實驗

第4章 心導管 - 正在開發的開發中產品:各企業

  • 心導管企業 - 各開發階段的開發中產品
  • 心導管 - 各開發階段的開發中產品

第5章 心導管企業與產品概要

  • AccuTherm Systems, Inc.
  • Andain, Inc
  • AngioDynamics, Inc.
  • Balch Hill Medical Group
  • Bioheart, Inc.
  • Boston Scientific Corporation
  • Boston TransTec, LLC
  • Cardiac Output Technologies, Inc.
  • Cardiovascular Systems, Inc.
  • Cordis Corporation
  • CorNova, Inc.
  • Delft University of Technology
  • Deliverance Ltd.
  • EndoCross Ltd.
  • EP Limited
  • Hadasit Medical Research Services & Development Ltd
  • Harvard University
  • MaRVis Technologies GmbH
  • Mayo Clinic
  • Medeon Biodesign, Inc.
  • Medical Device Investments, Inc.
  • Medikit Co., Ltd.
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Neovasc Inc.
  • Nesstent Ltd.
  • NeuroInterventional Therapeutics, Inc.
  • Northwestern University
  • Perseus Biomed Ltd.
  • Pi-Cardia Ltd
  • Pryor Medical Devices, Inc.
  • QualiMed Innovative Medizinprodukte GmbH
  • Rhythm Solutions
  • Therix Medical, Inc.
  • Topspin Medical Inc.
  • TransCardiac Therapeutics, LLC
  • Universite de Montreal
  • University of California, San Francisco
  • University of Limerick
  • Volcano Corporation
  • Voyage Medical

第6章 心導管 - 最近的趨勢

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0272EPD

GlobalData's Medical Devices sector report, "Cardiac Catheters - Medical Devices Pipeline Assessment, 2016" provides an overview of Cardiac Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cardiac Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiac Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiac Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Cardiac Catheters Overview

3 Products under Development

  • 3.1 Cardiac Catheters - Pipeline Products by Stage of Development
  • 3.2 Cardiac Catheters - Pipeline Products by Segment
  • 3.3 Cardiac Catheters - Pipeline Products by Territory
  • 3.4 Cardiac Catheters - Pipeline Products by Regulatory Path
  • 3.5 Cardiac Catheters - Pipeline Products by Estimated Approval Date
  • 3.6 Cardiac Catheters - Ongoing Clinical Trials

4 Cardiac Catheters - Pipeline Products under Development by Companies

  • 4.1 Cardiac Catheters Companies - Pipeline Products by Stage of Development
  • 4.2 Cardiac Catheters - Pipeline Products by Stage of Development

5 Cardiac Catheters Companies and Product Overview

  • 5.1 3DT Holdings, LLC Company Overview
    • 5.1.1 3DT Holdings, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 AccuTherm Systems, Inc. Company Overview
    • 5.2.1 AccuTherm Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 Andain, Inc Company Overview
    • 5.3.1 Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 AngioDynamics Inc Company Overview
    • 5.4.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 Avantec Vascular Corporation Company Overview
    • 5.5.1 Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 Balch Hill Medical Group Company Overview
    • 5.6.1 Balch Hill Medical Group Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 Boston Scientific Corp Company Overview
    • 5.7.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 Boston TransTec LLC Company Overview
    • 5.8.1 Boston TransTec LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9 Cardiac Output Technologies, Inc. Company Overview
    • 5.9.1 Cardiac Output Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10 Cardiovascular Systems Inc Company Overview
    • 5.10.1 Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11 Cordis Corp Company Overview
    • 5.11.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12 CorNova, Inc. Company Overview
    • 5.12.1 CorNova, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13 Delft University of Technology Company Overview
    • 5.13.1 Delft University of Technology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14 Deliverance Ltd. Company Overview
    • 5.14.1 Deliverance Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15 EndoCross Ltd. Company Overview
    • 5.15.1 EndoCross Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16 EP Limited Company Overview
    • 5.16.1 EP Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17 Georgia Institute of Technology Company Overview
    • 5.17.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18 Hadasit Medical Research Services & Development Ltd Company Overview
    • 5.18.1 Hadasit Medical Research Services & Development Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19 Harvard University Company Overview
    • 5.19.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20 MaRVis Technologies GmbH Company Overview
    • 5.20.1 MaRVis Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21 Mayo Clinic Company Overview
    • 5.21.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22 Mayo Clinic US Company Overview
    • 5.22.1 Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23 Medeon Biodesign, Inc. Company Overview
    • 5.23.1 Medeon Biodesign, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24 Medical Device Investments, Inc. Company Overview
    • 5.24.1 Medical Device Investments, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25 Medikit Co Ltd Company Overview
    • 5.25.1 Medikit Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26 Medtronic plc Company Overview
    • 5.26.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27 Merit Medical Systems, Inc. Company Overview
    • 5.27.1 Merit Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28 MicroPort Scientific Corporation Company Overview
    • 5.28.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29 Neovasc Inc Company Overview
    • 5.29.1 Neovasc Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30 Nesstent Ltd. Company Overview
    • 5.30.1 Nesstent Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31 NeuroInterventional Therapeutics, Inc. Company Overview
    • 5.31.1 NeuroInterventional Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32 Northwestern University Company Overview
    • 5.32.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33 Perseus Biomed Ltd. Company Overview
    • 5.33.1 Perseus Biomed Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34 Pi-Cardia Ltd Company Overview
    • 5.34.1 Pi-Cardia Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35 QualiMed Innovative Medizinprodukte GmbH Company Overview
    • 5.35.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.36 Rhythm Solutions Company Overview
    • 5.36.1 Rhythm Solutions Pipeline Products & Ongoing Clinical Trials Overview
  • 5.37 Sonix Therapeutics Company Overview
    • 5.37.1 Sonix Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
  • 5.38 Therix Medical, Inc. Company Overview
    • 5.38.1 Therix Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.39 Topspin Medical Inc. Company Overview
    • 5.39.1 Topspin Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.40 TransCardiac Therapeutics, LLC Company Overview
    • 5.40.1 TransCardiac Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.41 U.S. Stem Cell Inc Company Overview
    • 5.41.1 U.S. Stem Cell Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.42 Universite de Montreal Company Overview
    • 5.42.1 Universite de Montreal Pipeline Products & Ongoing Clinical Trials Overview
  • 5.43 University of California San Francisco Company Overview
    • 5.43.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
  • 5.44 University of Limerick Company Overview
    • 5.44.1 University of Limerick Pipeline Products & Ongoing Clinical Trials Overview
  • 5.45 University of Michigan Company Overview
    • 5.45.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
  • 5.46 Volcano Corp Company Overview
    • 5.46.1 Volcano Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.47 Voyage Medical (Inactive) Company Overview
    • 5.47.1 Voyage Medical (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.48 Weill Cornell Medical College Company Overview
    • 5.48.1 Weill Cornell Medical College Pipeline Products & Ongoing Clinical Trials Overview

6 Cardiac Catheters- Recent Developments

  • 6.1 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results
  • 6.2 Nov 18, 2016: Abbott Labs Prices Public Offering of 2.35% Notes due 2019 for USD2.9 Billion
  • 6.3 Nov 18, 2016: Abbott Labs Prices Public Offering of 2.9% Notes due 2021 for USD2.85 Billion
  • 6.4 Nov 18, 2016: Abbott Labs Prices Public Offering of 3.4% Notes due 2023 for USD1.5 Billion
  • 6.5 Nov 18, 2016: Abbott Labs Prices Public Offering of 3.75% Notes due 2026 for USD3 Billion
  • 6.6 Nov 18, 2016: Abbott Labs Prices Public Offering of 4.75% Notes due 2036 for USD1.7 Billion
  • 6.7 Nov 18, 2016: Abbott Labs Prices Public Offering of 4.9% Notes due 2046 for USD3.3 Billion
  • 6.8 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report
  • 6.9 Nov 15, 2016: Interim Report Vigmed Holding January - September 2016
  • 6.10 Nov 14, 2016: AngioDynamics Prices Public Offering of Shares for USD32 Million
  • 6.11 Nov 14, 2016: Neovasc Reports Third Quarter Results for 2016
  • 6.12 Nov 09, 2016: ICU Medical Announces Third Quarter 2016 Results
  • 6.13 Nov 09, 2016: AngioDynamics Announces Addition of New Board Members
  • 6.14 Nov 04, 2016: AngioSoma to Upgrade Its OmniCath Patents into OmniCath 2 Atherectomy Catheter
  • 6.15 Nov 03, 2016: Mattias Perjos appointed President and CEO of Getinge Group
  • 6.16 Nov 01, 2016: Endologix Reports Results for the Third Quarter 2016
  • 6.17 Oct 31, 2016: Guided Delivery Systems Announces Senior Leaders and Company Name Change to Ancora Heart
  • 6.18 Oct 27, 2016: Abiomed Announces Q2 FY 2017 Revenue of $103 Million, Up 35% Over Prior Year
  • 6.19 Oct 27, 2016: Stryker reports third quarter 2016 results
  • 6.20 Oct 27, 2016: Teleflex Reports Third Quarter 2016 Results
  • 6.21 Oct 27, 2016: Amedisys Previews Third Quarter 2016 Results
  • 6.22 Oct 27, 2016: Spectranetics Reports Third Quarter 2016 Revenue of $68.3 million
  • 6.23 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016
  • 6.24 Oct 26, 2016: Cardiovascular Systems Reports Fiscal 2017 First-Quarter Financial Results
  • 6.25 Oct 26, 2016: LeMaitre Q3 2016 Record Sales $23.2 mm (+22%), Record Op. Income $5.3 mm (+61%)
  • 6.26 Oct 26, 2016: Merit Medical Reports Sales Up 15.3% for the Quarter Ended September 30, 2016
  • 6.27 Oct 25, 2016: Baxter Reports Third Quarter 2016 Results and Increases Financial Outlook For Full-Year 2016
  • 6.28 Oct 25, 2016: Endologix Appoints Matthew Thompson, M.D., as Chief Medical Officer
  • 6.29 Oct 25, 2016: Edwards Lifesciences Reports Third Quarter Results
  • 6.30 Oct 25, 2016: Bard Announces Third Quarter Results
  • 6.31 Oct 25, 2016: Utah Medical Products Reports Financial Performance for Third Quarter 2016
  • 6.32 Oct 24, 2016: Vascular Solutions Reports Third Quarter Results
  • 6.33 Oct 19, 2016: Abbott Reports Third-Quarter 2016 Results
  • 6.34 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results
  • 6.35 Oct 18, 2016: Johnson & Johnson Reports 2016 Third-Quarter Results
  • 6.36 Oct 18, 2016: Further developed and focused strategy, and preparation for distribution of Patient & Post-Acute Care to shareholders of Getinge
  • 6.37 Oct 18, 2016: Getinge Interim Report January-September 2016
  • 6.38 Oct 14, 2016: Medline is Expanding Manufacturing in Georgia, and Adding Jobs
  • 6.39 Oct 13, 2016: Vigmed Signs Distribution Agreement For The Important Markets In The United Kingdom And Ireland
  • 6.40 Oct 12, 2016: Hydromer Announces Entering Into 2 Coating Service Agreements Leveraging Its Medical Device Subsidiary, Biosearch Medical Products
  • 6.41 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer
  • 6.42 Oct 05, 2016: AngioDynamics Reports Fiscal 2017 First Quarter Results
  • 6.43 Sep 27, 2016: MicroPort Hosts First EMEA Regional Distributor Summit
  • 6.44 Sep 15, 2016: STENTYS Reports 2016 First-Half Results
  • 6.45 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services
  • 6.46 Aug 31, 2016: Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China
  • 6.47 Aug 30, 2016: MPSC Announces 2016 Interim Results
  • 6.48 Aug 25, 2016: Medtronic Reports First Quarter Financial Results
  • 6.49 Aug 25, 2016: Interim Report Vigmed Holding January - June 2016
  • 6.50 Aug 22, 2016: Replacement of President & CEO Getinge Group:Joacim Lindoff appointed Acting President & CEO of Getinge Group
  • 6.51 Aug 22, 2016: Joacim Lindoff appointed Acting President & CEO of Getinge Group
  • 6.52 Aug 16, 2016: Cardiovascular Systems Names Scott Ward as CEO
  • 6.53 Aug 09, 2016: Neovasc Reports Second Quarter Results for 2016
  • 6.54 Aug 08, 2016: ICU Medical Announces Second Quarter 2016 Results
  • 6.55 Aug 04, 2016: Osprey Medical to Raise USD0.8 Million in Share Purchase Plan of CDIs
  • 6.56 Aug 03, 2016: Cardiovascular Systems Reports Fiscal 2016 Fourth-Quarter Financial Results
  • 6.57 Aug 03, 2016: U.S. Stem Cell Reports Positive Results for Q2 2016
  • 6.58 Aug 02, 2016: Endologix Reports Results for the Second Quarter 2016
  • 6.59 Jul 28, 2016: Spectranetics Reports Second Quarter 2016 Revenue of $67.7 million
  • 6.60 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016
  • 6.61 Jul 28, 2016: Teleflex Reports Second Quarter 2016 Results
  • 6.62 Jul 28, 2016: Abiomed Announces Q1 FY 2017 Revenue of $103.0 Million, Up 40% Over Prior Year
  • 6.63 Jul 27, 2016: Merit Medical Reports Sales Up 9.4% for the Quarter Ended June 30, 2016
  • 6.64 Jul 27, 2016: LeMaitre Q2 2016 Record Sales $22.4mm (+13%), Record Op. Income $3.8mm (+35%)
  • 6.65 Jul 27, 2016: AngioDynamics Issues Statement Regarding Stryker recall of Angiographic Catheters
  • 6.66 Jul 26, 2016: Merit Medical Announces Appointment of New Director
  • 6.67 Jul 26, 2016: Edwards Lifesciences Reports Second Quarter Results
  • 6.68 Jul 26, 2016: Bard Announces Second Quarter Results
  • 6.69 Jul 26, 2016: Utah Medical Products Reports Financial Performance for Second Quarter 2016
  • 6.70 Jul 26, 2016: Baxter Reports Second Quarter 2016 Results and Raises Financial Outlook for Full-Year 2016
  • 6.71 Jul 25, 2016: Vascular Solutions Reports Second Quarter Results
  • 6.72 Jul 25, 2016: AngioDynamics Appoints Michael C. Greiner as New Chief Financial Officer
  • 6.73 Jul 22, 2016: Angiodynamics Soft Vu Omni Flush Angiographic Catheter by Stryker Sustainability Solutions (formerly Ascent Healthcare Solutions): Class I Recall - Tip Separation
  • 6.74 Jul 21, 2016: Stryker reports second quarter 2016 results
  • 6.75 Jul 21, 2016: Federal Circuit Court Rules in Appeal
  • 6.76 Jul 20, 2016: Abbott Reports Second-Quarter 2016 Results
  • 6.77 Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results
  • 6.78 Jul 19, 2016: Johnson & Johnson Reports 2016 Second-Quarter Results
  • 6.79 Jul 14, 2016: Getinge Interim Report January-June 2016
  • 6.80 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors
  • 6.81 Jul 13, 2016: AngioDynamics Reports Fiscal 2016 Fourth Quarter and Full Year Results
  • 6.82 Jul 12, 2016: STENTYS: 41% Increase in Revenues in the Second Quarter of 2016
  • 6.83 Jul 12, 2016: McShane Construction Company Marks Significant Progress at New 630,000 S.F. Medical Supplies Distribution Center in Phoenix, Arizona
  • 6.84 Jul 08, 2016: Reed Construction Selected To Complete New Medline Headquarters
  • 6.85 Jul 07, 2016: Osprey Medical: Key Sales Milestones
  • 6.86 Jul 06, 2016: Cardiovascular Systems Submits Diamondback 360 Coronary Orbital Atherectomy System Micro Crown for Approval in Japan
  • 6.87 Jul 05, 2016: Neovasc Receives NASDAQ Notification Regarding Minimum Bid Requirements
  • 6.88 Jul 04, 2016: STENTYS: Appointment of Cardiolovascular Device Veteran as New CEO

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

  • Table 1: Cardiac Catheters - Pipeline Products by Stage of Development
  • Table 2: Cardiac Catheters - Pipeline Products by Segment
  • Table 3: Cardiac Catheters - Pipeline Products by Territory
  • Table 4: Cardiac Catheters - Pipeline Products by Regulatory Path
  • Table 5: Cardiac Catheters - Pipeline Products by Estimated Approval Date
  • Table 6: Cardiac Catheters - Ongoing Clinical Trials
  • Table 7: Cardiac Catheters Companies - Pipeline Products by Stage of Development
  • Table 8: Cardiac Catheters - Pipeline Products by Stage of Development
  • Table 9: 3DT Holdings, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Sizing Valvuloplasty Conductance Balloon Catheter - Product Status
  • Table 11: Sizing Valvuloplasty Conductance Balloon Catheter - Product Description
  • Table 12: AccuTherm Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: Thermal Sensing System - Product Status
  • Table 14: Thermal Sensing System - Product Description
  • Table 15: Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: Ultrasonic Catheter - Cardiac Catheterization - Product Status
  • Table 17: Ultrasonic Catheter - Cardiac Catheterization - Product Description
  • Table 18: AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 19: Coronary Angio Catheter - Product Status
  • Table 20: Coronary Angio Catheter - Product Description
  • Table 21: Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 22: Specialty Coronary Catheter - Product Status
  • Table 23: Specialty Coronary Catheter - Product Description
  • Table 24: Balch Hill Medical Group Pipeline Products & Ongoing Clinical Trials Overview
  • Table 25: PrecisionThread - Product Status
  • Table 26: PrecisionThread - Product Description
  • Table 27: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 28: Crossing Catheter - Product Status
  • Table 29: Crossing Catheter - Product Description
  • Table 30: Boston TransTec LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 31: Viper Catheter - Product Status
  • Table 32: Viper Catheter - Product Description
  • Table 33: Cardiac Output Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 34: Micro-Loop Catheter - Product Status
  • Table 35: Micro-Loop Catheter - Product Description
  • Table 36: Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 37: Diamondback 360 Coronary OAS Micro Crown - Product Status
  • Table 38: Diamondback 360 Coronary OAS Micro Crown - Product Description
  • Table 39: Diamondback 360 Coronary Orbital Atherectomy System - Product Status
  • Table 40: Diamondback 360 Coronary Orbital Atherectomy System - Product Description
  • Table 41: Cardiovascular Systems Inc - Ongoing Clinical Trials Overview
  • Table 42: Diamondback 360 Coronary Orbital Atherectomy System - Comparison of CSI's Diamondback 360 Coronary Orbital Atherectomy System (OAS) Versus Conventional Angioplasty (ECLIPSE trial)
  • Table 43: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 44: NOGA Guided Myostar Injection Catheter - Product Status
  • Table 45: NOGA Guided Myostar Injection Catheter - Product Description
  • Table 46: Cordis Corp - Ongoing Clinical Trials Overview
  • Table 47: NOGA Guided Myostar Injection Catheter - A Phase I, Open-label Study of the Effects of Percutaneous Administration of an Extracellular Matrix Hydrogel, VentriGel, Following Myocardial Infarction
  • Table 48: CorNova, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 49: FiberHalo SRM Post-Dilation Angioplasty Catheter - Product Status
  • Table 50: FiberHalo SRM Post-Dilation Angioplasty Catheter - Product Description
  • Table 51: FiberHalo SRM Pre-Dilation Angioplasty Catheter - Product Status
  • Table 52: FiberHalo SRM Pre-Dilation Angioplasty Catheter - Product Description
  • Table 53: FiberHalo SRM Stent Delivery Catheter - Product Status
  • Table 54: FiberHalo SRM Stent Delivery Catheter - Product Description
  • Table 55: Delft University of Technology Pipeline Products & Ongoing Clinical Trials Overview
  • Table 56: Multi-Steerable Catheter - Product Status
  • Table 57: Multi-Steerable Catheter - Product Description
  • Table 58: Multifunctional Catheter - CTO - Product Status
  • Table 59: Multifunctional Catheter - CTO - Product Description
  • Table 60: Deliverance Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 61: Laparoscopic Braided Sealer And Filler Catheter - Product Status
  • Table 62: Laparoscopic Braided Sealer And Filler Catheter - Product Description
  • Table 63: EndoCross Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 64: ENABLER-C Catheter System - Product Status
  • Table 65: ENABLER-C Catheter System - Product Description
  • Table 66: EndoCross Ltd. - Ongoing Clinical Trials Overview
  • Table 67: ENABLER-C Catheter System - The ENABLER 3C Study Is Investigating The Safety And Efficacy Of The ENABLER-C Catheter System In Facilitating Guidewire Advancement Through Chronic Total Occlusions In The Coronary Arteries
  • Table 68: EP Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 69: Laser Based Thermodilution Catheter - Product Status
  • Table 70: Laser Based Thermodilution Catheter - Product Description
  • Table 71: Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
  • Table 72: MRI Catheter - Product Status
  • Table 73: MRI Catheter - Product Description
  • Table 74: Hadasit Medical Research Services & Development Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 75: Double Lumen PCI Guiding Catheter - Product Status
  • Table 76: Double Lumen PCI Guiding Catheter - Product Description
  • Table 77: Harvard University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 78: Motion Compensated Catheter System - Product Status
  • Table 79: Motion Compensated Catheter System - Product Description
  • Table 80: MaRVis Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 81: MaRVis Catheter - Product Status
  • Table 82: MaRVis Catheter - Product Description
  • Table 83: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
  • Table 84: Acoustic Catheter - Product Status
  • Table 85: Acoustic Catheter - Product Description
  • Table 86: Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview
  • Table 87: Aortic Valve Guide Catheter - Product Status
  • Table 88: Aortic Valve Guide Catheter - Product Description
  • Table 89: Medeon Biodesign, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 90: IVC-C01 - Product Status
  • Table 91: IVC-C01 - Product Description
  • Table 92: Medical Device Investments, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 93: Cardiac/Carotid Aspirating Balloon Catheter - Product Status
  • Table 94: Cardiac/Carotid Aspirating Balloon Catheter - Product Description
  • Table 95: Ostial Stent Placement Catheter - Product Status
  • Table 96: Ostial Stent Placement Catheter - Product Description
  • Table 97: Medikit Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 98: I - Works - Product Status
  • Table 99: I - Works - Product Description
  • Table 100: Seiha - Product Status
  • Table 101: Seiha - Product Description
  • Table 102: Works - Product Status
  • Table 103: Works - Product Description
  • Table 104: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 105: Dxterity Diagnostic Catheter - Product Status
  • Table 106: Dxterity Diagnostic Catheter - Product Description
  • Table 107: Low Profile FFR Micro-catheter - Product Status
  • Table 108: Low Profile FFR Micro-catheter - Product Description
  • Table 109: Merit Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 110: Crossing Support Guide Catheter - Product Status
  • Table 111: Crossing Support Guide Catheter - Product Description
  • Table 112: Lamsano - Product Status
  • Table 113: Lamsano - Product Description
  • Table 114: MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 115: Catheter - Coronary Ischemia - Product Status
  • Table 116: Catheter - Coronary Ischemia - Product Description
  • Table 117: Intramyocardial Injection Catheter - Product Status
  • Table 118: Intramyocardial Injection Catheter - Product Description
  • Table 119: Neovasc Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 120: Ostial Flare - Product Status
  • Table 121: Ostial Flare - Product Description
  • Table 122: Nesstent Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 123: NesStent's catheter - Product Status
  • Table 124: NesStent's catheter - Product Description
  • Table 125: NeuroInterventional Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 126: Catheter - Carotid Stenting - Product Status
  • Table 127: Catheter - Carotid Stenting - Product Description
  • Table 128: DVT Intervention System - Product Status
  • Table 129: DVT Intervention System - Product Description
  • Table 130: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 131: Triple Balloon Occlusion/ Infusion Catheter - Product Status
  • Table 132: Triple Balloon Occlusion/ Infusion Catheter - Product Description
  • Table 133: Perseus Biomed Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 134: Intravascular Catheter - Chronic Disease - Product Status
  • Table 135: Intravascular Catheter - Chronic Disease - Product Description
  • Table 136: Pi-Cardia Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 137: LeafLex - Product Status
  • Table 138: LeafLex - Product Description
  • Table 139: Second Generation Leaflex Performer Catheter - Product Status
  • Table 140: Second Generation Leaflex Performer Catheter - Product Description
  • Table 141: QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 142: Biodegradable Catheter - Product Status
  • Table 143: Biodegradable Catheter - Product Description
  • Table 144: Rhythm Solutions Pipeline Products & Ongoing Clinical Trials Overview
  • Table 145: Cardiovascular Catheter - Gene Therapy - Product Status
  • Table 146: Cardiovascular Catheter - Gene Therapy - Product Description
  • Table 147: Sonix Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
  • Table 148: Percutaneous Ultrasonic Drug Delivery System - Product Status
  • Table 149: Percutaneous Ultrasonic Drug Delivery System - Product Description
  • Table 150: Therix Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 151: Cardiac Diagnostic Catheter - Product Status
  • Table 152: Cardiac Diagnostic Catheter - Product Description
  • Table 153: Topspin Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 154: IntraVascular MRI catheter - Product Status
  • Table 155: IntraVascular MRI catheter - Product Description
  • Table 156: TransCardiac Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 157: EndoCardiac Navigator - Product Status
  • Table 158: EndoCardiac Navigator - Product Description
  • Table 159: U.S. Stem Cell Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 160: MyoCath - Product Status
  • Table 161: MyoCath - Product Description
  • Table 162: MyoCath II - Product Status
  • Table 163: MyoCath II - Product Description
  • Table 164: Universite de Montreal Pipeline Products & Ongoing Clinical Trials Overview
  • Table 165: Multifunction Catheter - Product Status
  • Table 166: Multifunction Catheter - Product Description
  • Table 167: University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
  • Table 168: Cardiac Catheter - Product Status
  • Table 169: Cardiac Catheter - Product Description
  • Table 170: Delivery Catheter - Product Status
  • Table 171: Delivery Catheter - Product Description
  • Table 172: University of Limerick Pipeline Products & Ongoing Clinical Trials Overview
  • Table 173: Pre-Hydrate Catheter - Product Status
  • Table 174: Pre-Hydrate Catheter - Product Description
  • Table 175: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
  • Table 176: Integrated Dual Lumen Catheter - Product Status
  • Table 177: Integrated Dual Lumen Catheter - Product Description
  • Table 178: Volcano Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 179: Preview - Product Status
  • Table 180: Preview - Product Description
  • Table 181: Voyage Medical (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 182: IRIS Transseptal Catheter - Product Status
  • Table 183: IRIS Transseptal Catheter - Product Description
  • Table 184: Weill Cornell Medical College Pipeline Products & Ongoing Clinical Trials Overview
  • Table 185: Zone Isolation and Bypass System - Product Status
  • Table 186: Zone Isolation and Bypass System - Product Description
  • Table 187: Glossary

List of Figures

  • Figure 1: Cardiac Catheters - Pipeline Products by Stage of Development
  • Figure 2: Cardiac Catheters - Pipeline Products by Segment
  • Figure 3: Cardiac Catheters - Pipeline Products by Territory
  • Figure 4: Cardiac Catheters - Pipeline Products by Regulatory Path
  • Figure 5: Cardiac Catheters - Pipeline Products by Estimated Approval Date
  • Figure 6: Cardiac Catheters - Ongoing Clinical Trials
Back to Top